Patent: 9,499,619
✉ Email this page to a colleague
Summary for Patent: 9,499,619
Title: | Polyclonal bispecific antibody compositions and method of use |
Abstract: | The invention relates to compositions and methods for treating a host infected with a pathogen. The composition comprising a population of polyclonal bispecific binding molecules that can target and eliminate a host cell infected with the pathogen. Methods for activating and arming cytotoxic immune cells with the composition for use in treating a patient infected with a pathogen are also provided. |
Inventor(s): | Lum; Lawrence G. (Harrison Township, MI), Huang; Manley (Palo Alto, CA) |
Assignee: | TRANSTARGET, INC. (Burlingame, CA) WAYNE STATE UNIVERSITY (Detroit, MI) |
Application Number: | 14/637,194 |
Patent Claims: | see list of patent claims |
Details for Patent 9,499,619
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Saol Therapeutics Research Limited | CYTOGAM | cytomegalovirus immune globulin intravenous (human) | Injection | 103189 | 04/17/1990 | ⤷ Try a Trial | 2029-11-06 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |